Uzzo et al. demonstrated that zinc treatment could inhibit angiogenic activity in PCa cells, predominantly through modulating MAPKs, NF-κB and several angiogenic factors, including VEGF, IL-6, IL-8 and MMP-9 [71]. The gene discussed is MMP9; the disease is posterior cortical atrophy.